Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer (Q24653339)

2

Emmanuelle Charafe-Jauffret

0 references

Gilles Houvenaeghel

6

Gilles Houvenaeghel

0 references

Jocelyne Jacquemier

1

Jocelyne Jacquemier

0 references

Daniel Birnbaum

9

Daniel Birnbaum

0 references

author name string

Florence Monville

3

0 references

Benjamin Esterni

4

0 references

Jean Marc Extra

5

0 references

Luc Xerri

7

0 references

François Bertucci

Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway

8

0 references

language of work or name

English

0 references

publication date

2009

0 references

published in

Breast Cancer Research

0 references

volume

11

0 references

issue

2

0 references

page(s)

R23

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Repeated observation of breast tumor subtypes in independent gene expression data sets

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

FOXA1 as a therapeutic target for breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

How to best classify breast cancer: conventional and novel classifications (review).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Microcomputer-based nonlinear regression analysis of ligand-binding data: application of Akaike's information criterion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.

30 May 2018

1 reference

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

21 January 2018

1 reference

Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study

21 January 2018

1 reference

Androgen receptors as a prognostic and predictive factor in breast cancer.

21 January 2018

1 reference

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

21 January 2018

1 reference

Prognosis of Breast Cancer and Gene Expression Profiling Using DNA Arrays

21 January 2018

1 reference

FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers

21 January 2018

1 reference

The significance of GATA3 expression in breast cancer: a 10-year follow-up study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688952

FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19405945

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

FOXA1 Expression in Breast Cancer Correlation with Luminal Subtype A and Survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19405945

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR2249

1 reference

Dimensions Publication ID

1024533889

0 references

1 reference

1 reference

PubMed publication ID

19405945

1 reference